Assessing Symptom and Mood Dynamics in Pain Using the Smartphone Application SOMA
Part of paid clinical trials in Providence, Rhode Island.
- Sponsor
- Brown University
- Study ID
- NCT05754190
- Status
- Recruiting
Conditions
- Acute Pain
- Arthritis
- Chronic Headache Disorder
- Chronic Low-back Pain
- Chronic Migraine
- Chronic Pain
- Chronic Pain Syndrome
- Chronic Pelvic Pain Syndrome
- Chronic Shoulder Pain
- Endometriosis-related Pain
- Failed Back Surgery Syndrome
- Fibromyalgia
- Fibromyalgia, Primary
- Fibromyalgia, Secondary
- Irritable Bowel Syndrome
- Neuropathic Pain
- Painful Bladder Syndrome
- Painful Diabetic Neuropathy
- Post Herpetic Neuralgia
- Post Operative Pain
- Temporomandibular Joint Disorders
- Trauma, Multiple
- Trauma-related Wound
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - N/A
- Healthy Volunteers
- Accepted
Interventions
- SOMA pain manager smartphone application — DEVICESOMA is a smartphone application developed for acute and chronic pain patients to track daily mood and pain symptoms and overall activity.
Study Details
This study relies on the use of a smartphone application (SOMA) that the investigators developed for tracking daily mood, pain, and activity status in acute pain, chronic pain, and healthy controls over four months.The primary goal of the study is to use fluctuations in daily self-reported symptoms to identify computational predictors of acute-chronic pain transition, pain recovery, and/or chronic pain maintenance or flareups. The general study will include anyone with current acute or chronic pain, while a smaller sub-study will use a subset of patients from the chronic pain group who have been diagnosed with chronic low back pain, failed back surgery syndrome, or fibromyalgia. These sub-study participants will first take part in one in-person EEG testing session while completing simple interoception and reinforcement learning tasks and then begin daily use of the SOMA app. Electrophysiologic and behavioral data from the EEG testing session will be used to determine predictors of treatment response in the sub-study.
Key Dates
- Start date
- Jun 20, 2023
- Status verified
- Sep 2025
- Primary completion
- May 30, 2026
- Completion
- May 30, 2026
Study Design
- Enrollment
- 800 participants (estimated)
Arms
- Arm: Healthy Controls\[general study + sub study\] No history of chronic pain
- Arm: Acute pain\[general study\] Pain duration \< 3 months
- Arm: Chronic pain\[general study\] Pain duration \> 6 months \[sub-study\] diagnosis of chronic low back pain, failed back surgery syndrome, or fibromyalgia
Primary Outcome Measure
[General Study] Acute-Chronic Pain Transition Probability [ Time Frame: T1 [4 months of daily app use] ]
Central Contacts
- Frederike H Petzschner, PhD401-863-6272
- Chloe S Zimmerman, MD/PhD student401-863-6272
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Brown University | Providence | Rhode Island | 02912 | Frederike H Petzschner, PhD (PRINCIPAL_INVESTIGATOR) |
Find similar trials in Providence, RI
Related Studies
- Proof of Concept Trial of Cannabis Derivatives in Neuropathic PainPHASE2 · Recruiting · VA Office of Research and Development · San Diego, California
- HOnest Placebos With Explanations: Evaluating Open-Label Placebos for Chronic PainRecruiting · Rhode Island Hospital · Providence, Rhode Island
- Video Intervention for Older Adults With Chronic PainRecruiting · Butler Hospital · Providence, Rhode Island
- A Study of Brenipatide (LY3537031) in Participants With Irritable Bowel Syndrome-Diarrhea (IBS-D)PHASE2 · Recruiting · Eli Lilly and Company · Mesa, Arizona